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Abstract
Background: While mental health professionals have focused on concerns about whether antidepressants work on
a neurochemical level it is important to understand the meaning this medication holds in the lives of people who
use it. This study explores diversity in the experience of antidepressant users.
Methods: One thousand seven hundred forty-seven New Zealand antidepressant users responded to an open-
ended question about their experience of antidepressants. This was analysed using content and thematic analysis.
Results: There was considerable diversity in participants’ responses including positive (54 %), negative (16 %) and
mixed (28 %) experiences with antidepressants. Those with positive experiences saw antidepressants as a necessary
treatment for a ‘disease’, a life saver, a way of meeting social obligations, dealing with difficult circumstances or a
stepping stone to further help. Negative themes described antidepressants as being ineffective, having unbearable
side effects, undermining emotional authenticity, masking real problems and reducing the experience of control.
Mixed experience themes showed how participants weighed up the unpleasant side effects against the benefits,
felt calmer but less like themselves, struggled to find the one or dosage and felt stuck with continuing on
antidepressants when they wished to stop.
Conclusions: Mental health professions need to recognize that antidepressants are not a ‘one size fits all’ solution.
Keywords: Depression, Antidepressants, Patient experiences, Medication use
Background
Antidepressants are being prescribed at high levels
across the developed world [1, 2]. In New Zealand,
where this study was undertaken, an estimated one in
nine adults receives prescriptions every year [3]. Profes-
sional debate has typically focused on whether antide-
pressants ‘work’ on a neurochemical level [4, 5] with
users being viewed as relatively passive recipients of
medical decision-making [6]. However there is an
important body of research recognising that people are
actively involved in making meaning of their medication
use and that this has implications this has for the value it
has in their lives [7–10]. Small scale qualitative research
has often highlighted negative experiences [11–14] or
noted considerable ambivalence amongst some anti-
depressant users [15, 16]. Only a very limited amount of
research has attempted to understand positive experiences
of antidepressants, also using small samples [17].
Research suggests a range of factors predict different
experiences of antidepressants, including demographic
factors, psychosocial factors, people’s belief about de-
pression, and their relationship with their prescriber
[18]. Some users react differently to the same anti-
depressant [19] while different antidepressants produce
different effects [20]. In addition, there is likely to be
some fluidity in people’s views through their ‘journey’
with antidepressants [21, 22]. Most of the qualitative
studies that inform this area also recognize that while
people actively make meaning of their experiences of
medication use, they do so in the context of prevailing
social ideas that help to shape the way that these can be
thought about [23]. Currently people make sense of their
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antidepressant use against a contested terrain in which
antidepressants are represented as an effective strategy
for treating a bio-medicalised conception of depression
[24] alongside concerns over the over-prescription and
misuse of this medication [1, 25].
An understanding of users’ own experiences of anti-
depressant use is increasingly important in the context
of growing doubts about the effectiveness of antidepres-
sant treatment [5, 26], concerns about side effects [27]
and withdrawal effects [28]. With less certainty amongst
professionals that antidepressants necessarily ‘do some
good’ [29], it important to gather feedback on how users
themselves experience the value or otherwise of these
medications in their lives.
This article analyses the responses of a large sample of
antidepressant users to an open-ended survey question
on the impact that antidepressants had on participants’
lives. Our analysis aims to explore the potential diversity
of experiences with antidepressants and the meanings at-
tributed to them.
Methods
This article draws from responses to one open question
in an anonymous online survey exploring the experience
of adult New Zealanders prescribed antidepressants. The
question asked participants to complete the phrase: “In
my life antidepressants have been…” The study was ap-
proved by the University of Auckland, Human Partici-
pants Ethics Committee and participants gave informed
consent for their participation.
Participants
Participants were informed of an online survey via wide-
spread media advertising. The criteria for participation
included having been prescribed antidepressants in the
last five years, living in New Zealand and being 18 years
of age or over. The survey was available online from
March 2012 until January 2013. There were 1,829 com-
pleted surveys for analysis. The majority of the sample
was women (77 %). The modal age group was 36-45
(24.2 %); 16.3 % were 18 to 25, and 15.9 % were 56 or
older. Population figures suggest that 13.7 % of the New
Zealand population is 65 or older [30] while only 3.6 %
of our sample were over 65. The sample also appeared
to have a somewhat higher education than the general
population with 49.6 % reporting they had a university
degree; 26.1 % gained a diploma or certificate after high
school, 17.2 % completed high school, and 7.1 % did not
complete high school as compared with 14.2 % of adult
New Zealanders who had an undergraduate degree or
higher and 22.4 percent who had no formal qualification
in 2006 [31]. The annual income of this sample ranged
from less than NZ$10,000 (15.0 %) to over NZ$100,000
(7.7 %). The modal income was $40,000 to $59,999 (22.1
%) as compared to the median income of the New
Zealand population in 2012 which was $29,000 [30].
Nearly all participants (97 %) had taken the antide-
pressants when prescribed them, and 69 % were still tak-
ing antidepressants. Just over half (51.7 %) had taken
them for more than three years, and 7.8 % for less than
three months. Of the 1,715 (93.8 %) who answered a
question about which antidepressant they had been pre-
scribed, the most common was Fluoxetine (22.4 %),
followed by Citalopram (20.3 %), Paroxetine (8.7 %),
Tricyclics (4.5 %) and Venlafaxine (2.2 %). Thirty nine
percent reported that they had been prescribed multiple
antidepressants.
The question analysed in this article was only com-
pleted by those who reported that they had actually
taken antidepressants following a prescription (1747 par-
ticipants or 97 % of the total survey sample of 1829).
Data analysis
Participants’ responses, ranged from one word answers
through to about 400 words. In order to analyse this
large number of responses an initial content analysis was
used to generate a quantitative description of the data
and provide an overarching framework for a more de-
tailed analysis [32]. Three pre-determined categories
were used to code each participant’s response as a whole:
‘positive’, ‘negative’ and ‘mixed’ as well as a separate
category for those who did not answer the question as it
was intended. The coding was performed by the first
author. Ten percent of responses were blind coded by
the second author to check for consistency and areas of
ambiguity or difference were addressed in the final cod-
ing. As there was high agreement in the initial cross-
coding, further checks were not required.
Thematic analytic methods were used to identify
themes within each of the three content categories.
Braun & Clarke’s method provided the framework for
this analysis, which involved initially identifying and cod-
ing key ideas [33]. This process was continued until the
point of saturation [34]. Codes were then linked together
into themes that reflected a shared meaning.
Results
The content analysis showed that 54 % (939) of partici-
pants gave a positive account of antidepressants in their
lives. Sixteen percent (273) of participants reported
predominantly negative experiences and 28 % (489) de-
scribed ‘mixed’ experiences. Two percent of responses
did not fall into any of these categories (e.g. an elabor-
ation of symptoms of depression).
Positive experiences of antidepressants
In keeping with neurochemical explanations of depres-
sion many participants described antidepressants as a
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necessary treatment for a ‘mental illness’ often referring
to the ‘serotonin deficiency hypothesis’ which sees
depression as a result of a chemical imbalance, as the
following participant explained: [Its] just like diabetes –
a chemical shortage…I need serotonin uptake inhibitors
– simple!” These participants saw antidepressants as a
necessary and ongoing treatment for an underlying dis-
ease: “I would hope that one day I could stop taking
them but realize that for me it is the same as taking
heart pill for someone else.”
This illness framework sometimes involved resignation
that the participant needed to remain on antidepressants
indefinitely, as one participant explained: “My GP said
that if I had diabetes I would need to take insulin for-
ever, so not to worry that I appear to need to continue
to take anti-depressants forever.”
While some participants described antidepressants as
a rational treatment for a disease, other responses con-
veyed a stronger emotional investment in antidepressant
use. A number simply described them as ‘a life-saver’
conveying a sense of the distress which had led them to
take antidepressants and the relief they experienced once
on antidepressants: “I can still remember the desperation
and pain and if it meant taking them forever I would not
hesitate.” A number of people elaborated the idea of an-
tidepressants as a life-saver in more literal form, imply-
ing that medication had prevented them from
committing suicide. As one participant put it, ‘I truly feel
that I would not be alive if I had not taken them”.
A third theme within the positive responses character-
ized antidepressant use as enabling ‘normal’ social func-
tioning. [Antidepressants are] the sole reason I can now
function as normally as possible as a human being and a
participating member of my family and community.”
Part of this seemed to be that antidepressants allowed
them to better fulfill the demands of their social roles.
As one participant put it: “[they have been] very helpful,
they have allowed me to be a better parent than I would
have otherwise been, I believe.”
A fourth theme was somewhat different, describing
antidepressants as a temporary way of dealing with chal-
lenging circumstances – including interpersonal and so-
cial problems. Participants alluded to a range of difficult
circumstances as the following response suggestions:
“[Antidepressants are] helpful in enabling me to manage
the stresses of job loss and unemployment. I feel that I
can cope better with job interviews on them.”
In some cases, antidepressants were seen not so much
as a solution on their own but as a ‘stepping stone’ to
some other kind of strategy or support as the following
response suggests:
I have had such good therapy that I have been able to
address the wider issues that had contributed to my
mental state. …Without the medication though, I
would never have had the ability to do this.
For participants who understood antidepressants this
way, the medication was generally seen as a temporary
solution with therapy providing the more lasting benefit.
Negative experiences of antidepressants
For a number of participants negative experiences of an-
tidepressants were underpinned by a belief that antide-
pressants were simply ineffective: “They were a waste of
time and did not help me”. Some actively contested the
idea that medication could be more helpful than other
self-directed strategies of coping: “I get more benefit
from mild to moderate exercise, or energy drinks, or
spending quality time with friends.” Other participants
wrote that they had initially had expectations that anti-
depressants would help them and had become in-
creasingly disillusioned with their experience, as the
following participant describes: “[They were] greatly
disappointing. I wish I had never tried them, because
before I tried them at least there was hope that
something could have helped.”
The unpleasant side effects of antidepressants
formed a second dominant theme in the negative cat-
egory of responses with a number of participants
explaining that they had struggled with the various
side effects of different medicines over what appeared
to be a lengthy period of time:
Each one has had a worse effect than the previous…. I
can’t remember them all. It started with memory loss
then progressed to me becoming borderline catatonic
staring at the wall for hours unable to stand up.
Within a few weeks and genuinely terrified. It was a
relief to go back to the misery of depression after
these experiences.
For some participants the journey to find an anti-
depressant that did not produce adverse effects had be-
come the primary focus of their lives: “[It’s been] a never
ending struggle to find the right ones that do not pro-
duce adverse health problems.”
Another of the prevalent theme amongst the negative
experience responses related to concerns with emotional
numbing and the loss of emotional authenticity. A num-
ber of participants wrote of feeling “like a zombie.” One
participant elaborated on how he understood antidepres-
sants to ‘work’: “They don’t make the problems go away.
They just make me numb enough to not give a shit.”
Another explained how the emotional numbness
impacted on her life more generally: “By taking the
medication I felt alienated from others almost as though
I was walking around like a zombie in a kind of bubble.”
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A related theme suggested that antidepressant use was
felt to invalidate the genuine suffering participants had
experienced. As the following participant put it: “In my
life antidepressants have been prescribed to me to cover
up what was wrong, and to me were a fake fix.” Some
people also wrote about how antidepressants had led
them to tolerate circumstances which they would have
done better to address directly: “I believe that I stayed in
a relationship that was unhealthy for me, because the
antidepressants made me tolerate treatment that was
unacceptable.”
A final negative theme captured the way that partici-
pants felt that antidepressants had undermined their
control over their lives. For some taking antidepressants
seemed to raise fears of personal weakness. For example,
several participants wrote about using antidepressants as
a sign of failing to “cope” or as a sign of dependency:
[It’s] like smoking. When you smoke you know it’s
bad for you, but you also feel momentary relief and
therefore can’t (or don’t want to stop) because you
miss that feeling of being slightly more capable to
handle situations.
A small number of participants linked their lack of
control while on antidepressants to the lack of power
over treatment options they experienced in relation to
their treatment more generally:
I felt bullied into keeping taking them and at times
told I would not receive therapeutic treatment if I
didn’t take them. There felt like no alternative and I
felt very trapped into taking them.
Mixed experiences of antidepressants
Many participants wrote about how using antidepres-
sants entailed a constant struggle to balance perceived
benefits of the medication with side effects. For example,
one participant described antidepressants as “a necessary
evil, with very unfortunate side effects in terms of weight
gain and sexual dysfunction which lead to me stopping
the treatment despite its benefits for my mood.” Partici-
pants wrote particularly about sexual side effects and
how they had to weigh up the negative impact of antide-
pressants on their intimate relationships with the bene-
fits they felt antidepressants provided to these same
relationships. While some, like the previous participant,
had ended up stopping antidepressants because of side
effects, others resigned themselves to living with these:
I know they do me good and I am better on them, but
they do make me feel physically sick, and not like
myself. I seem to be constantly trying life without
them, but always go back to them in the end.
A second theme illustrated how participants felt grate-
ful that antidepressants took the edge off their distress
but also struggled with a sense that they did not feel ‘like
themselves’:
Antidepressants have been a two edged sword. I felt
less affected by things that would normally distress
me while on anti-depressants… [but] when I came off
them, my head felt clear, I felt like I was waking up
and that I was in touch with myself again.
Another participant reflected on a similar dilemma in
which she appeared to weigh up the benefits in terms of
reduced feelings of depression and changes in the way
she related to others:
[Antidepressants were] helpful in making my
depression less. However, the effects that they had on
me as a person and how I treated others is the main
reason I came off them. I am a considerate and
selfless person and while on the antidepressants I was
the complete opposite.
A third mixed theme showed how participants actively
balanced the concerns about being ‘dependent’ on them
with their fears about their depression returning if they
stopped taking the medication. One participant explained
how she become so used to being on antidepressants and
was afraid of how things would be without them:
The thing is that I have been on them so long that I
have no idea what it would be like not to be on them.
I would love to come off them but they have become
such a ‘normal’ part of my life since I was
approximately 15 years old that I am not sure I would
cope without them.
Some participants implied that there had been little
follow-up or advice on how to come off antidepressants
as one participant wrote:
They helped me get back on my feet when I was
facing a difficult time. However I was never told when
to go off them and …have not heard from the doctor
who prescribed them to me in years.
Participants also described how withdrawal effects
made it especially difficult to come of the medication:
The withdrawal effects if I forget to take my pill are
severe shakes, suicidal thoughts, a feeling of too much
caffeine in my brain, electric shocks, hallucinations,
insane mood swings. [I’m] kinda stuck on them now
coz I’m too scared to come off it.
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In contrast to responses which emphasized balancing
concerns and perceived benefits of antidepressants,
some attributed their mixed experience of antidepres-
sants to the variable effects of the different medications
they had been prescribed while for others they felt there
had been changes in their own response to a single anti-
depressant over time. A few participants described how
antidepressants appeared to have been initially effective
but became less so over time in spite of increased dos-
ages, and for others their response varied markedly with
the different medications they had tried:
I have been on MANY different antidepressants. None
of them were helpful at all to me until I tried Fluoxetine
4 years ago. My life now is greatly improved by taking
this medication and a quality of life has returned.
The responses of many of these participants seemed to
capture the struggle of taking different medications over
time and struggling to find the one that worked for them:
I have tried almost all antidepressants available under
prescription (including combinations), and most
worked to varying amounts to start with, then
stopped helping, then the dose was increased, then
stopped working/made me worse, then dose increased
to the maximum, then stopped working, then I was
put on something else. I’ve wondered if I would
have been better off never starting taking them at
all (see Table 1 here).
Discussion
This research points to the inadequacy of asking the
simple question: ‘Do antidepressants work?’ Instead, the
value or otherwise of antidepressants needs to be under-
stood in the context of the diversity of experience and
the particular meaning they hold in people’s lives. Our
research suggests that meanings underpinning positive
experiences of antidepressants are much less homoge-
neous than we might have anticipated.
In spite of limited scientific support for the idea that
antidepressants correct a chemical imbalance, partici-
pants have clearly been influenced by myths about ‘sero-
tonin deficiency’ which are widely promoted to the
general public [35]. However there were a range of other
meanings attributed to antidepressant use which went
well beyond bio-medical considerations. Some partici-
pants saw them as having both real and metaphorical
life-saving properties while other suggested more tem-
porary and pragmatic uses in relation to meeting social
obligations, dealing with difficult circumstances or as a
stepping stone to other forms of help. The diversity of
Table 1 Content categories and themes
Content categories
N 1747
Positive experiences of antidepressants Negative experiences of antidepressants Mixed experiences of antidepressants
54 % (n 939) 16 % (n 273) 28 % (n 489)
Positive themes Example of coded data Negative themes Example of coded data Mixed themes Example of coded data
Necessary for
disease treatment
No different to a diabetic
taking their insulin.
Ineffective Useless despite trying
several different kinds.
Benefits vs side effects Very unfortunate side effects in
terms of weight gain and sexual
dysfunction which lead to me
stopping the treatment despite
its benefits for my mood and
anger issues.
A life saver Antidepressants have been
a lifeline, without them I
would be dead.
Unbearable side
effects
A major cost to my
sex life
Calmer but not myself Good at removing my anxiety
and fear but it made me feel
dead inside.
Meeting social
obligations
The medication I’m on is
assisting me to function as
an individual and to work
and contribute to the
community and society and
to cope with things in my
workplace.
Loss of
authenticity/
Emotional
numbing
Feel alienated from
myself and my
emotions.
Fear of dependence
versus stopping
medication
Very useful but I am now too
scared to come off them and
constantly worry about long
term effects of being on
citalopram 20mg per day
Getting through
difficult times
Helpful for getting through
a busy, tiring and stressful
time in my life.
Masks real
problems
A distraction that
means I don’t address
the real issue.
Finding one that
works
Useless until I found the one
that worked for me.
A stepping stone
to further help
Provided the ‘lift’ I’ve
needed to get started
with other things like CBT,
regular exercise etc.
Loss of control A sign of failing to
cope.
Content category: Other 2 % (n 46)
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meaning suggests that users may be appropriating the
medication in different ways according to their own pri-
orities and concerns.
This research also suggests that a large number of
people may be to some extent dissatisfied with their anti-
depressant use. The number of participants who reported
some degree of negative experience constitutes a signifi-
cant proportion (44 %) of the overall sample. Some experi-
enced little benefit from antidepressants while the side
effects, particularly more subtle psychological effects such
as feeling numb or ‘not like themselves,’ seemed a signifi-
cant issue, which was also found to affect many partici-
pants in the analysis of the general survey data [36]. The
research also raised concerns that, in some cases, man-
aging the side effects of antidepressants might take prior-
ity over managing the depression or circumstances that
helped to produce it. Participants were also concerned
about the medication undermining the legitimacy of their
suffering and undermining their sense of control.
Overall, the purely negative responses were far fewer
than the ambivalent responses which point to the strug-
gle that a significant proportion of people may experi-
ence in choosing to use antidepressants. The search for
the right antidepressant at the right dosage may be a
long and frustrating journey for some. Experimentation
with dosage may also by risky insofar as research sug-
gests that higher dosages do not necessarily produce in-
creased efficacy but may result in greater problems with
withdrawal [37]. For users, staying on antidepressants
may involve an on-going negotiation between perceived
benefits and the problems they are seen to cause. This
research also raises concerns about whether people re-
main on antidepressants despite their misgivings because
of fears that they would not be able to cope without
medication, withdrawal effects and lack of support from
their mental health providers to manage this process.
Conclusion
It is important for mental health professionals to
recognize that antidepressants are not a ‘one size fits all’
solution. They need to enter into dialogue with anti-
depressant users to explore the meaning antidepressants
hold in their lives and the extent to which these enable or
constrain their ability to make informed choices about
their use. In making decisions about whether to take
antidepressants, users should not be given misleading
information about a known chemical aetiology in depres-
sion. They should instead be fully informed about the
existing research on the efficacy of antidepressants relative
to or in combination with psychosocial treatments [38]. In
addition they might be usefully referred to research on
user’s experiences [18] as well as receive full information
about common side effects [27, 36] and withdrawal effects
[28] so that they can make informed treatment choices.
The findings of this study should be interpreted in the
context of its limitations. The volunteer sample might
well favor responses from people who have a stronger
investment in the issue, such as those who had been on
antidepressants for longer. Certainly, more than half the
participants in this study had been on antidepressants
for more than 3 years. A volunteer sample is also likely
to attract those with stronger views about antidepres-
sants. In this study, 84 % of participants in this study
answered in the affirmative to a question about whether
they felt antidepressants had reduced their depression,
a number well above that suggested by efficacy studies
[5, 26]. This suggests that the findings of this study
might over-represent positive responses to antidepres-
sants. In addition the format of internet survey might
have restricted the extent to which participants felt able
to elaborate more complex or ambivalent responses.
Using an internet survey might also have skewed the
sample towards a more educated and financially well-
resourced group of participants and favoured a more
youthful sample. The overrepresentation of women (76.6
%) is a less significant bias as they are prescribed antide-
pressants at much higher rates than men [39]. Concerns
have been raised about limited access of potential partici-
pants to the internet but it has been recognised that this is
changing quickly over time and varies considerably from
one country to another [40]. In New Zealand, 80 % of
households are reported to have access to internet [41].
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